The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
about
Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic miceA novel persistence associated EBV miRNA expression profile is disrupted in neoplasiaEpstein-Barr virus latent genesIdentification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome.Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.The LMP2A ITAM is essential for providing B cells with development and survival signals in vivoMechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2ASignaling activities of gammaherpesvirus membrane proteinsAn Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationEpstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersEBNA-LP associates with cellular proteins including DNA-PK and HA95.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.Evolutionary aspects of oncogenic herpesvirusesImmortalization of human primary B lymphocytes in vitro with DNA.Molecular virology of Epstein-Barr virus.Epstein-barr virus-induced changes in B-lymphocyte gene expression.The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infectionAn integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues.Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJkEpstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo.Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transductionEpstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitroThe EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.Epstein-Barr virus recombinants from overlapping cosmid fragments.Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.
P2860
Q24524255-8A32B8BA-0CDC-42FF-8674-250741E9CD7FQ27349177-FD72D130-9791-4869-B65C-2944C06B696AQ28082701-641509E6-B838-4E79-9AB5-2F4C6D2D90F5Q30175290-29C176C5-F667-4480-BAA1-3A33E3652CE0Q33598586-8EFBA7FF-7BB1-4EFE-98FC-70128113FB54Q33604616-2BA4D44A-DFDE-4679-B944-19AC54D0ED55Q33653017-501646A8-3CCC-4135-8C5F-9B7EBCC221C4Q33787090-8D3E7450-8445-4120-82D8-2366AB6E640EQ33794029-10F02A9B-BD8C-45BC-AC8B-067820319466Q33822504-48E6F5B6-E2F0-4EED-AA3E-D677DC97F060Q33825713-5EDCEA90-C574-48DA-9A3F-8F8DCB0141A1Q33843054-52F8C92A-7E9C-4EAD-A5A7-CAE9407D33D2Q33845947-F8AE0BB3-B4E4-45B3-B70E-89493BAA588CQ33850943-DDE49741-5FD3-46C6-A0DD-27C99D9FF5D0Q33918592-075D3F9A-6242-4935-84D8-2BA6B429352CQ33998709-2ED50F58-5F23-4474-AF74-7A5D5F624DBDQ34089478-3A9CD61C-4A98-40D0-90C7-93C263088020Q34160976-F15AFE56-C2EB-48B3-9CCD-2239FAE336C5Q34225554-8E1F1218-D864-43FB-B4BC-54720A55E4D5Q34347958-117E54F0-80BE-4570-A912-6A6650462637Q34545445-99D78B4B-24E1-4A55-91D5-F23F6EB3A0B6Q35000168-631EB6D2-794C-44D6-9FC5-A3CA055C8FF5Q35661383-BD38CA76-DE1B-46D5-A542-47ED2B791210Q35831016-75E8A9F5-11FB-4C79-9D23-AEA31DAEC606Q35835726-C396416B-ED0E-4FB1-8339-6B88B08B9977Q35839108-259338DE-FECA-4A24-B071-48DAB57211A8Q35852557-DFA434D8-F3C7-42C9-83A3-9F6CD4FB566CQ35857975-A03CBEF0-2779-49FE-94D9-4B1933E6AFC5Q35868359-EEC17E08-51DC-4709-A864-D49EE4FF36FEQ35875444-4CDEBCCD-FF1B-4A42-A7AC-E276D987065FQ35887119-201C0481-ABC5-47F3-AC15-EC7D2075D59AQ35948025-A4F7AD9B-9439-4991-9D7F-803F123126A1Q36205880-E814DD02-E262-4324-BC49-46892A9F3D96Q36575274-546A494E-36D2-4412-A151-093E88B647ECQ36628631-AF15924D-0F9B-4FBF-97B5-4FFF04897E9EQ36635773-55B7589F-4CBA-4361-90F4-E8ECED0EFBD9Q36646940-E78AE2AD-2FE3-42F2-8686-079125571FDCQ36651589-34856520-B2FC-4C3F-AE22-82A31C124998Q36655212-623A0C63-2D94-4ED6-97FA-A25040120421Q36655549-C8800393-55E5-4D9C-8186-B3ECE3545B43
P2860
The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
The last seven transmembrane a ...... rowth transformation in vitro.
@ast
The last seven transmembrane a ...... rowth transformation in vitro.
@en
type
label
The last seven transmembrane a ...... rowth transformation in vitro.
@ast
The last seven transmembrane a ...... rowth transformation in vitro.
@en
prefLabel
The last seven transmembrane a ...... rowth transformation in vitro.
@ast
The last seven transmembrane a ...... rowth transformation in vitro.
@en
P2093
P2860
P1433
P1476
The last seven transmembrane a ...... growth transformation in vitro
@en
P2093
P2860
P304
P407
P577
1993-04-01T00:00:00Z